Natco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), Dr Ramesh Dandala, superannuates
Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API) of the Company.
This announcement follows the earlier supperannuation of Tummala Venkata Rao, Vice President - Production of the Company, further indicating shifts within Natco Pharma’s executive team.
In March, the Company appointed Bhimrao Dattu Jadhav as Senior Vice President - Operations (Formulations) for Pharma Division - Kothur of the Company.
NATCO Pharma Limited, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. The Company is a R&D oriented, and a science driven, leading Oncology player in the targeted therapies of domestic market and focuses on limited competition molecule in the US. The Company has 9 manufacturing sites and 2 R&D facilities in India. The Company’s manufacturing facilities are approved by several leading regulatory authorities like US FDA, Brazil ANVISA, Health Canada, WHO and others catering to 50+ global markets.
Read also: Natco Pharma Tummala Venkata Rao supperannuates as Vice President - Production
